Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells

Cellular Signalling
Mihaela GurguiGerhild van Echten-Deckert

Abstract

Sphingosine 1-phosphate (S1P) is involved in the local inflammatory response within the intestinal muscularis, which has been suggested to play a major role in the pathogenesis of postoperative ileus. The aim of the present study was to elucidate the role of S1P and the molecular mechanisms underlying regulation of inflammatory mediators in primary cultured rat intestinal smooth muscle (RISM) cells. Although our experimental data clearly show the mediatory role of sphingosine kinase (SK)-derived S1P in the TNF-alpha and the LPS induced activation of NF-kB, exogenously added S1P failed to trigger this transcription factor. Instead, exogenous S1P induced early growth response-1 (Egr-1), which was reported to play a proinflammatory role in postoperative ileus. Using RNA interference we found that Egr-1 is required primarily for S1P-induced expression of IL-1 and COX2. Conversely, IL-6 expression following S1P treatment was mediated by STAT3 (signal transducer and activator of transcription-3). In addition our data indicate that the proinflammatory effect of S1P is mediated by its receptors S1P(1-3) and requires activation of MAP-kinases. In conclusion, Egr-1 and STAT3 cooperatively mediate S1P-induced inflammatory responses in RIS...Continue Reading

References

Dec 1, 1990·Journal of the American Society of Nephrology : JASN·V P Sukhatme
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·P XiaM A Vadas
May 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A J AmmitR A Panettieri
Jun 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y OsawaH Moriwaki
Jan 5, 2002·The Journal of Biological Chemistry·Pu XiaMathew A Vadas
Oct 18, 2002·Journal of Cellular Physiology·Gerald Thiel, Giuseppe Cibelli
May 3, 2003·Nature Reviews. Molecular Cell Biology·Sarah Spiegel, Sheldon Milstien
Aug 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Benjamin J PettusYusuf A Hannun
Mar 17, 2004·The Journal of Biological Chemistry·Brigitte Anliker, Jerold Chun
Jun 11, 2004·Annual Review of Biochemistry·Isao IshiiJerold Chun
Feb 4, 2006·Circulation Research·Levon M Khachigian
Mar 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Snigdha MishraDavid J Pinsky
Aug 1, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mihaela DragusinGerhild van Echten-Deckert
Mar 3, 2007·Biochemical and Biophysical Research Communications·Chi-Iou LinHsinyu Lee
Feb 19, 2008·The Journal of Biological Chemistry·Elke HoffmannMichael Kracht
Feb 3, 2009·Cancer Cell·Jacqueline Bromberg, Timothy C Wang

❮ Previous
Next ❯

Citations

Nov 5, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Saminathan MuthusamyJaleh Malakooti
Oct 10, 2012·Free Radical Biology & Medicine·Paola MatarreseCarola Severi
Sep 26, 2014·Nature Communications·Vagner R R SilvaEduardo R Ropelle
Apr 22, 2016·American Journal of Physiology. Cell Physiology·Justin R SysolRoberto F Machado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.